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ABSTRACT
Objective To evaluate the association between umbilical
cord pH at birth and long term outcomes.
Design Systematic review and meta-analysis.
Data sources Medline (1966-August 2008), Embase
(1980-August2008),theCochraneLibrary(2008issue8),
andMedion,withoutlanguagerestrictions;referencelists
of selected articles; and contact with authors.
Study selection Studies in which cord pH at birth was
comparedwithanyneonatalorlongtermoutcome.Cohort
and case-control designs were included.
Results 51 articles totalling 481753 infants met the
selection criteria. Studies varied in design, quality,
outcomedefinition,andresults.Meta-analysiscarriedout
withinpredefinedgroupsshowedthatlowarterialcordpH
was significantly associated with neonatal mortality
(odds ratio 16.9, 95% confidence interval 9.7 to 29.5,
I
2=0%), hypoxic ischaemic encephalopathy (13.8, 6.6 to
28.9, I
2=0%), intraventricular haemorrhage or
periventricular leucomalacia (2.9, 2.1 to 4.1, I
2=0%), and
cerebral palsy (2.3, 1.3 to 4.2, I
2=0%).
Conclusions Low arterial cord pH showed strong,
consistent, and temporal associations with clinically
important neonatal outcomes that are biologically
plausible. These data can be used to inform clinical
management and justify the use of arterial cord pH as an
important outcome measure alongside neonatal
morbidity and mortality in obstetric trials.
INTRODUCTION
Perinatalasphyxiaisamajorcauseofneonatalandchild-
hood morbidity and mortality and has been associated
with neonatal death
1;h y p o x i ci s c h a e m i ce n c e p h a l o p a -
thy and seizures
23; intraventricular haemorrhage
4;c e r e -
bral palsy
5; and delayed development.
5 Perinatal
asphyxia is predicated by fetal acidosis, determined by
umbilical cord pH at birth.
6Cerebral palsy is thought to
occur more frequently at an arterial cord pH of <7.00
and a base deficit of ≥12 mmol/l.
7 These criteria, how-
ever,havebeenderivedthroughconsensus,notthrough
evaluation of collated summaries of evidence,
7 leading
toclinicaluncertainty.
8Thisisbecauseexistingobserva-
tional studies of the association between cord pH and
outcomes have drawn inconsistent inferences, partly as
aresultofthedifferentthresholdsusedtodefineabnorm-
ality,thevarietyofoutcomesevaluated,andthedifferent
variables measured (arterial cord pH, venous cord pH,
or base excess).
9-11 It has been suggested that neonatal
complications are associated with metabolic rather
than respiratory acidosis.
1213 Respiratory acidosis arises
in the early stages of impaired blood supply to the fetus;
hypoxaemia and hypercapnia occur, leading toa reduc-
tioninpHwithanormalbaseexcess.
6If hypoxia is pro-
longed, anaerobic metabolism results and base excess
rises secondary to the presence of lactic acidosis.
On the basis of nine studies, a review
14 claimed an
association between fetal acidosis and neonatal death
and cerebral palsy. This review was, however, carried
outinthelate1990s,duringwhichtimenewstudieson
the subject have been published and guidelines pro-
ducedonthemethodologyandreportingofsystematic
reviews, including quality assessment of included stu-
dies, which were not in widespread use at the time of
the review’s publication.
15 Substantial uncertainty
thereforeremainsaboutthevaluecliniciansmayattach
to acidosis in the clinical management of neonatesand
the long term implications of a low arterial cord pH.
However, cord pH is also commonly used as an out-
come measure in obstetric clinical trials
16-18 and it is
one of the bench marks by which obstetricians judge
their performance on the labour ward.
19 A documen-
ted lowcord pHisa factorthatmaybeusedtosupport
medico-legal claims of harm during intrapartum
events resultingin long term disability.
20 It is therefore
imperative that the validity of this association is sup-
ported with high quality evidence. We carried out a
comprehensive systematic review of the literature to
quantitatively establish the strength of association of
acidosis at birth with neonatal mortality, morbidity,
and long term outcomes and to assess if causal criteria
were met.
21
METHODS
This systematic review was protocol driven using
widely recommended methods for reviews
22-24 and
evaluation of causal associations.
2125-28 The review
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MOOSE guidance.
15
We searched Medline (1966-August 2008), Embase
(1980-August2008),theCochraneLibrary(2008issue
8),andMedionforrelevantpublishedarticles.Toiden-
tify “grey” literature we also searched SIGLE, Web of
Science, the national research register, and medical
conferences register. For the Medline search (also see
web extra on bmj.com) we used a combination of
MeSH headings, such as umbilical cord, hydrogen-
ion concentration, or asphyxia neonatorum; key-
words, such as umbilical artery pH and cord pH; and
wordvariantsusing“OR”forcapturingcitationsofthe
relevant text. To capture relevant outcomes we com-
binedtheseusing“AND”withacombinationofMeSH
headings,suchashumandevelopmentandinfantmor-
tality; keywords, such as developmental delay and
handicap; and word variants. We restricted the search
to human studies but applied no language restrictions.
We adapted the Medline search strategy for use in
other databases. We also hand searched recent major
journals. Two investigators (RKM and GLM) carried
out the search. Using Reference Manager 11.0, we
constructed a comprehensive database collating all
citations.
Study selection and data extraction
Tworeviewers(RKMorGLM,partlyinduplicate)scru-
tinised the database and obtained full articles of all cita-
tions potentially meeting the predefined selection
criteria. Translations of articles in languages other than
Englishwereobtained.Tworeviewers(GLMandRKM
or ZL) included orexcluded studiesin accordance with
themostrecentguidance,
23usingstrictadherencetothe
following criteria: population—infants with cord blood
obtained at birth; index test—cord blood examined for
arterial or venous pH or base excess; outcome—any
measure of compromise of neonatal or childhood well-
being, such as mortality; neonatal morbidity, including
hypoxic ischaemic encephalopathy, seizures, intra-
ventricularhaemorrhage,periventricularleucomalacia,
and long term outcomes, including cerebral palsy; and
study design—observational studies that allowed gen-
eration of a 2×2 table (true positives, false positives,
false negatives, and true negatives) to compute an esti-
mate of the association between test result and out-
comes. We excluded studies with five or fewer cases,
because of unreliability.
The manuscripts were examined for duplicated
populations. If any were found we selected the most
recent and complete version. No language restrictions
were applied in study selection. We scrutinised the
reference lists of selected studies and review articles
and obtained additional relevant articles. Two
researchers(GLMandRKMorZL)usedadatacollec-
tion sheet to extract information in duplicate from the
selected articles. Data were extracted on study charac-
teristics,quality,andresults,andenteredontoanExcel
spreadsheet. Data were used to construct 2×2 tables of
the association between the cord blood variable at the
threshold reported in the paper and the postnatal out-
come for each infant. When data were thought to be
relevant but 2×2 tables could not be constructed, we
contacted the relevant authors. Difficulties in data
extraction were resolved by discussion with a third
reviewer (KSK).
Study quality assessment
We assessed those articles meeting the selection cri-
teria for methodological quality, defined as the confi-
dence that the study design, conduct, and analysis
minimised bias in estimation of the association. The
articles were assessed using the complete STARD
and QUADAS checklists.
2930 These are guidelines for
reporting, and methodological quality of, studies on
diagnostic accuracy. As the focus of this review was
to determine association, the checklist items thought
to be most relevant were selected for the purpose of
defining the overall quality of included studies and to
divide the studies according to quality for meta-analy-
sis and metaregression, in accordance with published
guidance.
23Wedidnotassignaqualityscoreasthishas
beenshowntogiveflawedresults.
31Weconsideredthe
cohort study design to be superior to the case-control
Studies identified from electronic searches,
from inception to August 2008 (n=5690)
Citations excluded (n=5315)
Potentially relevant articles obtained in full manuscripts (n=444):
  Identified from electronic searches (n=375)
  Identified from manual checking of reference list (n=69)
Articles excluded from review with reasons (n=393):
  Not umbilical cord pH (n=146) 
  Inappropriate outcome measure (n=79)       
  Lack of original data (review articles or letters) (n=60)
  Duplicate publications (n=6)
  Incorrect population (n=1)
  Data not extractable (four studies presented data as
    mean) (n=82)
  Case series ≤5 (n=16)
  Papers unavailable (n=3)
Selected for inclusion in systematic review
  (n=51, 481 753 infants)
Test
Arterial cord pH
Venous cord pH
Arterial base excess
Venous base excess
No of studies
46
6
4
1
No of infants
479 022
2531
549
25
Primary articles included that evaluated arterial cord pH
  (n=46, 479 022 infants)
Outcome measure
Neonatal mortality*
Composite neonatal morbidity*
  Hypoxic ischaemic encephalopathy*
  Seizures*
  Intraventricular haemorrhage or
    periventricular leukomalacia*
Cerebral palsy*
Comprehension and reading ability 
Intelligence
Speech or language
Global development
Movement disorder
*Pooled in meta-analyses
No of studies
15
30
7
9
12
7
1
2
3
3
1
No of infants
469 365
10 904
827
5191
284
1117
116
41
423
359
44
Fig 1 | Study selection process
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Studies Risk factors Index tests Outcome measures
High risk population:
Baenziger et al 1999
50 All ventilated neonates; risk factors for HIE, including meconium
liquor, abnormalities on cardiotocogram, low Apgar score or pH,
gestation >34 weeks
Arterial cord pH <7.00 Death*; hypoxic ischaemic encephalopathy (Sarnat grade >1)*;
neurological optimality score (age 1 year); Griffiths developmental
scale (age 1 year)
Beeby et al 199
44 Gestation <32 weeks; excluded congenital anomalies Arterial cord pH <7.1 Death*; cerebral palsy (age 1 year); intraventricular haemorrhage
grade 3 or 4 on cranial ultrasound scan or at autopsy*
Blackwell et al 2001
52 All neonates requiring ventilation >48 hours for meconium aspiration
syndrome; gestation >37 weeks
Arterial cord pH <7.2 Seizures*
Bresadola et al 1995
51 Gestation >24 weeks, <37 weeks; birth weight >700 g; excluded
congenital anomalies
Arterial cord pH <7.2 Death*
Casey et al 2001
53 Neonates who developed respiratory symptoms postnatally;
gestation >37 weeks
Arterial cord pH <7.2 Death*; seizures*; respiratory distress requiring ventilation*;
meconium aspiration syndrome*
Engle 1999
56 Neonates admitted to neonatal unit directly from delivery suite;
gestation >37 weeks
Arterial cord pH <7.00 Hypoxic ischaemic encephalopathy including seizures*
Ertan 2001
91 Gestation 24-34 weeks ArterialcordpH<7.10;
arterial base excess
>16 mmol/l
Intracranial haemorrhage (Papile, all grades) on cranial ultrasound
scan*
Gaudier et al 1994
49 Birth weight 500-1000 g; gestation 23-34 weeks; excluded
congenital anomalies
Arterial cord pH <7.05 Wechsler intelligence scale for children (IQ <70); cerebral palsy (chronic
non-progressive motor disability characterised by abnormal posture and
movements), follow-up to age 7 years; motor or mental deficit severe
enough to interfere with normal function, including one or more of mental
retardation, cerebral palsy, deafness, blindness, or hydrocephaly
Gea 2007
93 Birth weight <2000 g; gestation <37 weeks; excluded congenital
anomalies, maternal diabetes, and rhesus incompatibility
VenouscordpH<7.20;
venous base excess
>10 mmol/l
Periventricular or intraventricular haemorrhage on cranial ultrasound
scan*; ventilation >24 hours*; necrotising enterocolitis (Bell grade 2)*
Gonzalez de Dios et al 2000
59 Atleastoneriskfactorforasphyxia(forexample,Apgarscore<6,cordpH
<7.00, antenatal risk factors); excluded if congenital anomaly, sepsis,
metabolic disorder, postnatal depression; gestation >37 weeks
Arterial cord pH ≤7.00 Serum creatinine level >1.2 mg/dl*; hypoxic ischaemic
encephalopathy (Levine’s criteria, all grades)*; abnormal neurological
status (Amiel-Tison criteria), age 2 years
Graham et al 2004
61 Gestation 23-34 weeks Arterial cord pH <7.00 Periventricular leucomalacia or ventricular dilatation on cranial
ultrasound scan*
Haddad et al 2000
62 Neonates with Apgar score 0 at 1 and 5 minutes, resuscitated and
transferred to neonatal unit; excluded congenital malformations,
chromosome abnormalities, birth before arrival; gestation 25.5-42.
1w e e k s
Arterial cord pH <7.00 Death*; hypoxic ischaemic encephalopathy*
Hernandez et al 1993
63 Clinicalandradiologicalevidenceofmeconiumaspirationsyndrome;
excluded if congenital anomalies, cytomegalic inclusion disease,
delivery outside hospital
Arterialcord pH<7.00,
<7.10, and <7.20
Ventilation required*; ventilation ≥3d a y s *
Hibbard et al 1991
64 Birth weight 500-1500 g Arterial cord pH ≤7.05
and ≤7.15
Death*; intraventricular haemorrhage (Papile grade 1-4) on cranial
ultrasound scan*; abnormal neurological status defined as seizures,
cortical atrophy, need for shunt placement*; hyaline membrane
disease (chest radiography)*; bronchopulmonary dysplasia (chest
radiography)*; necrotising enterocolitis*
Holmes et al 2001
66 Birth weight 750-2500 g; gestation 25-35 weeks; excluded if
caesarean section before labour, congenital anomalies,
uninterpretable fetal heart rate trace
Arterial cord pH <7.10 Death*; intraventricular haemorrhage (Papile grade 3 or 4)*;
periventricular leucomalacia*
Kato 1997
5 Birth weight <1500 g. Congenital anomalies excluded Arterial cord pH <7.20 Death*; cerebral palsy or mental retardation (at least 12 months old)
Loh et al 1998
72 Included if one or more of following risk factors: abnormality on
cardiotocogram, scalp pH<7.25, thick meconium or no liquor, cord
prolapse or bradycardia, antepartum haemorrhage, estimated fetal
weight<1500g,gestation<34weeks,breech,poorlycontrolledtype1
diabetes, pre-eclampsia, suspected fetal anomalies, transverse or
oblique lie at caesarean section, multiple pregnancies
Arterial cord pH <7.00 Hypoxic ischaemic encephalopathy
Luthy et al 1987
74 Gestation 26-32 weeks; excluded multiple pregnancy, non-cephalic
presentation, malformations, delivery before labour, antenatal
haemorrhage
Arterial cord pH ≤7.20 Death; cerebral palsy (age 18 months); intraventricular haemorrhage
on cranial ultrasound scan (Papile grade 3 or 4)*
Murphy et al 1995
75 Gestation 23-32 weeks; excluded multiple pregnancy Arterial cord pH ≤7.10 Cerebral palsy (permanent impairment of voluntary movement or
posture), age unreported
Salafia et al 1995
78 Gestation <32 weeks; excluded if congenital anomalies, multiple
pregnancy, maternal diabetes mellitus or chronic hypertension, fetal
hydrops, placenta praevia, intrauterine growth restriction
ArterialcordpH<7.10;
venous cord pH <7.10
Germinal matrix or intraventricular haemorrhage diagnosed on cranial
ultrasound scan (grade 1-4)*
Socol 1994
81 Apgar score ≤3 at 5 minutes; excluded birth weight <2000 g and
gestation <34 weeks
ArterialcordpH<7.00;
arterial base excess
>12 mmol/l
Cerebral palsy or motor deficit (age 1-7 years); seizures*; renal
impairment (serum creatinine level >1.5 mg/dl, or oliguria)*; cognitive
impairment on Wechsler scale (cut off <70), age 1-7 years
Spinillo et al 1995
82 Birth weight <2500 g Arterial cord pH <7.20 Bayley index abnormal (71-84), age 2 years
Tejani and Verma 1989
83 Birth weight ≤2000 g; excluded major congenital anomalies Arterial cord pH ≤7.10 Death*; intraventricular haemorrhage on cranial ultrasound scan
(Papile grade 1-4)*; respiratory distress syndrome (radiological
evidence of reticulogranular pattern and air bronchograms)*
Yudkin et al 1994
89 Apgar score ≤3 at 1 minute; gestation >37 weeks; excluded multiple
pregnancies and death related to congenital anomaly or rhesus
disease
Arterial cord pH <7.15 Death*; any impairment (age 5 years); serious impairment (global
delay, lateralising signs and severe deficit in a specific area), age
5y e a r s
Yoon et al 1996
88 Gestation 25-36 weeks; excluded major congenital malformations or
death before examination
Arterial cord pH <7.15 Periventricularleucomalaciaoncranialultrasoundscanoratautopsy*
RESEARCH
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Unselected or low risk population:
Dennis et al 1989
54 Gestation >37 weeks; singletons surviving to age 4.5 years ArterialcordpH≤7.10;
arterial base excess
>12 mmol/l
Griffiths developmental scales age 4.5 years: locomotor, personal or
social, hearing and speech, performance, and overall impairment
Dijxhoorn et al 1986
41 Gestation >37 weeks; excluded caesarean delivery or breech
presentation
Arterial cord pH ≤7.10
and ≤7.20
Neurological status (abnormal if one of hyperkinesias or hypokinesia,
hypertonia or hypotonia, hemisyndrome, apathy syndrome, or
hyperexcitability syndrome)*
D’Souza et al 1983
55 Normal pregnancy, vaginal delivery 39-42 weeks Venous cord pH <7.27 Neurological status (abnormal if one of hypotonia, lethargy, feeding
difficulties, jittery)*
Ghosh et al 2003
57 Gestation>37weeks;singletonsexcludedifrhesusisoimmunisation,
maternal anaemia, or diabetes mellitus
Arterial cord pH ≤7.15 Hypoxic ischaemic encephalopathy*; death*
Gilstrap et al 1989
58 Gestation >37 weeks, cephalic presentation, birth weight >2500 g;
excluded congenital anomalies
Arterial cord pH <7.00 Hypotonia >24-48 hours*; respiratory distress requiring oxygen*;
seizures*
Graham 2002
60 Excluded congenital anomalies Arterial cord pH <7.00 Seizures*
Heller et al 2003
1 Excluded congenital anomalies ArterialcordpH≤7.00,
≤7.10, and ≤7.20
Death*
Hogan 2007
65 Gestation >37 weeks Arterial cord pH ≤7.15 Composite reference standard hypoxic ischaemic encephalopathy
(Sarnat, all grades) or hypoxic death*
Huisjes and Aarnoudse 1979
67 Population characteristics unreported Arterial cord pH ≤7.09 Abnormal neonatal neurological status (Prechtl method)*
Ingemarrson et al 1997
68 Population characteristics unreported Arterial cord pH <7.05
and <7.00
Death*; cerebral palsy (age 4 years); impact of events scale (Sarnat
grade 1-3)*; attention deficit (age 4 years); speech difficulty (age
4 years); motor delay (age 4 years)
Jurgens- van der Zeeet al 1979
69 Neonates;excludedifneonataldeathorparentsrefusedexamination Venous cord pH <7.20 Abnormalneurological examinationresult(Prechtl method):1or more
of increased or decreased excitability including seizures, apathy or
coma; abnormal motility or tone; peripheral or central nervous system
lesions*
Larma et al 2007
70 Gestation ≥24 weeks Arterial cord pH <7.00 Seizures*; periventricular leucomalacia*; intraventricular
haemorrhage*; respiratory dysfunction*; renal dysfunction*
(thresholds unreported)
Litschgi et al 1974
71 Population characteristics unreported Arterial cord pH <7.09 Abnormal neurological examination result (24 hours after birth)*
Low 1997
73 Gestation ≥37 weeks Arterial base excess
>12 mmol/l
Composite outcome score*; neurological abnormality (lethargy,
abnormal tone, coma, or seizures)*; respiratory dysfunction
(continuous positive airway pressure or ventilation required)*;
cardiovascular dysfunction (hypotension, hypertension, abnormal
electrocardiogram or echocardiogram)*; renal dysfunction (serum
creatinine level >100 umol/l, anuria, or oliguria <1 ml/kg/h)*
Perlman and Risser 1996
76 Gestation ≥37 weeks Arterial cord pH ≤7.00 Seizures*
Sakuraba and Saling 1989
77 Population characteristics unreported Arterial cord pH ≤7.19
and ≤7.24
Intracranial haemorrhage diagnosed on cranial ultrasound scan*
Schneider and Tanner 1985
79 Twins only included Arterial cord pH <7.20 Binet Simon Kramer (intelligence); language test; emotional
intelligence test; Raven intelligence test (non-spoken); neurological
status (all tests carried out at age 5-7 years)
Silva et al 2008
80 Gestation ≥34 weeks; excluded congenital malformations and
chromosome anomalies
Arterial cord pH <7.00
and <7.10
Hypotonia at birth necessitating admission to neonatal unit*; hypoxic
ischaemic encephalopathy*; seizures*
Svirko et al 2008
92 Gestation ≥36 weeks; one of reference tests done and cord pH
available; excluded if delivered by prelabour elective caesarean
section
Arterial cord pH <7.10 Wechsler objective reading dimensions (age 6-8 years); test for
comprehensionofgrammar (age5-7 years); Naglierinon-verbalability
(age 6-8 years); cut off <100 age standardised score used for all tests
Thoulon et al 1972
84 Population characteristics unreported Venous cord pH <7.20 Death*; abnormal neurological examination (age 18 months)
Valentin et al 1993
85 Anomalies not excluded Arterial cord pH ≤7.00
and ≤7.10; venous
cord pH ≤7.10 and
≤7.20
Compositemeasureofneonatalsequelae,includingseveresymptoms
requiring treatment (for example, ventilation, intravenous fluids),
death, or survival with sequelae*
Van den Berg 1996
10 Excludedchromosomalormajorcongenitalanomaliesorintrauterine
infection
Arterial cord pH <7.00
(compared withgroup
of neonates with cord
pH >7.24)
Seizures*; intracranial haemorrhageon cranial ultrasound scan*;
periventricular leucomalacia oncranial ultrasound scan*; renal
impairment(serumcreatininelevel>90µmol/l*);abnormalliverfunction
(aspartatetransaminase level >33 U/l, alanine aminotransferase level
>25 U/l)*; necrotising enterocolitis (criteria unreported)*
Vintzileos et al 1993
90 Gestation ≥26 weeks; excluded known congenital or chromosomal
anomalies
Arterial cord pH <7.10 Death*
Wildshut et al 2005
11 Gestation37-42weeks;neonatesincludedifgrowthbetween2.3and
97.7th centiles, vertex position, stay in hospital at least 3 days after
birth; excluded if hypoxia ischaemia other than caused by perinatal
adverse conditions. Exclusions included meconium aspiration,
respiratory distress syndrome, infection, birth after complicated
pregnancy, congenital malformations, maternal medication, alcohol
or drug misuse, metabolic disorders
Arterial cord pH <7.10 Movement ABC test (score <16 or unable to perform due to movement
disorder), age 4 years
Winkler 1991
86 Gestation ≥37 weeks Arterial cord pH <7.20 Composite reference standard: seizures or neonatal death*
Wu et al 1998
87 Gestation ≥37 weeks; singletons only Arterial cord pH <7.19 Motor delay; speech delay; difficulty concentrating (all assessed age
4y e a r s )
*Outcomes within neonatal period.
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ariate in metaregression. Because of the small number
of studies included in each meta-analysis we did not
thinkitappropriatetoconsidereachremainingquality
item as an individual covariate for metaregression,
32
and we therefore divided the studies into two cate-
gories on the basis of several criteria. We rated a
study as being of high quality if it had at least four of
the following items: adequate description of popula-
tion, adequate description of the test and outcome
measure,consecutiverecruitment,prospectiverecruit-
ment, more than 90% completion of follow-up, appro-
priate outcome measurement, blinding of the
investigators carrying out the outcome measure, and
a statement on the use of intervention between the
index test and outcome. When a study adhered to
three or fewer of these criteria we considered it to be
of medium or low quality.
Data synthesis
We used 2×2 tables to compute odds ratios and 95%
confidenceintervalsforeachpairofindextestandout-
come. The odds ratio was selected as the summary sta-
tistic as it is relatively constant regardless of the test
threshold
33 and is often used to show an epidemiologi-
calassociation.
34Itrepresentstheeffectoftheexposure
ontheoddsinanunbiasedfashionandenableslinkage
between the results of case-control and cohort
studies.
34 As the focus of this review was to establish
theassociationbetweencordpHandadverseoutcome
ratherthanthevalueofcordpHasaprognostictest,we
did not calculate other summary statistics (including
sensitivity,specificity,andlikelihoodratios).Wecalcu-
lated the estimated predictive interval for each meta-
analysis, which relates to the effect of a new study that
would be eligible for inclusion in meta-analysis and
therefore allows the full uncertainty around inferences
to be calculated, including both magnitude and
consistency.
35
When tables contained cells with a value of 0, we
added 0.5 to these cells to allow the calculation of
variances.
36 Analyses were done for groups defined a
prioriaccordingtoindextest(arterialcordpH,venous
cord pH, and base excess). The main outcome mea-
sures consideredwere neonatalmortality,a composite
measure ofneonatalmorbidity, and cerebralpalsy.To
maximise the number of events that could be included
in the analysis and to avoid the need to select a single
morbidity as a primary outcome measure, we used a
composite outcome measure for neonatal morbidity.
However, a hazard of composite outcome measures
is the assumption that the significance of the result
applies to all components.
37 To deal with this, we ana-
lysed the component outcomes of hypoxic ischaemic
encephalopathy, seizures, intraventricular haemor-
rhage,orperiventricularleucomalacia.Whenthecom-
posite outcome measure was used, we took care to
ensure that each individual was counted only once in
each analysis, particularly when studies reported mul-
tiple outcomes for a single population. When multiple
outcomes and test thresholds were reported, we
attempted to select the most consistent threshold and
outcome across the composite analysis—for example,
wherestudiesreportedonhypoxicischaemicencepha-
lopathy, seizures, and intraventricular haemorrhage,
we included hypoxic ischaemic encephalopathy and
seizures in the meta-analysis as we believed this to be
more clinically consistent and overall the more com-
mon outcome across the included studies.
We plotted odds ratios data in forest plots, assessing
heterogeneityvisuallyandstatisticallyusingtheI
2statis-
tic, a scale that measures the degree of heterogeneity
across studies in a meta-analysis.
38 Within the largest
groups(arterialcord pHpairedwithneonatalmortality
and neonatal morbidity) we explored the reasons for
heterogeneity using metaregression, planned a priori
in keeping with published recommendations.
3940 We
considered study design (cohort v case-control), study
quality (high v medium or low), and population risk
(high v low/unselected or unreported) as potential
sources of heterogeneity. We defined a population at
high risk for complications on the basis of reported
characteristics, including abnormalities on cardio-
tocograms, meconium liquor, a low Apgar score at
birth, gestation less than 37 weeks, and birth weight
less than 2500 g. It was not possible to use a low risk
population as comparator because only one included
study met the criteria for this definition.
41 Given the
reporting quality of the primary studies it was also not
possible to explore other potential sources of heteroge-
neity. Metaregression analysis was univariate through-
out, in accordance with published guidance that
recommends allowing at least 10 studies per covariate
explored.
42 When a reason for heterogeneity was iden-
tified, we carried out subgroup analyses. As complica-
tions such as cerebral palsy and intraventricular
haemorrhage have been shown to be increased in pre-
term and low birthweight infants we analysed studies
with these populations separately and compared the
results with that of a term population.
As clinical heterogeneity was present between stu-
dies, we used a random effects model throughout.
Table 2 |Methodological quality of studies in systematic review of association between low
cord pH at birth and neonatal and long term morbidity
Quality item
No (%) of studies (n=51)
Yes No Unclear
Cohort study design 42 (82) 9 (18) 0
Population adequately described 40 (78) 2 (4) 9 (18)
Consecutive recruitment 2 (4) 1 (2) 48 (94)
Prospective recruitment 15 (29) 29 (57) 7 (14)
Appropriate outcome measure 51 (100) 0 0
Outcome measure blinded 7 (14) 0 44 (86)
>90% of infants had outcome measure 41 (80) 10 (20) 0
Index test and outcome measure described 8 (16) 12 (24) 31 (61)
Intervention between index test and outcome 0 0 51 (100)
Quality classification:
High 23 (45) 0 0
Medium 0 20 (39) 0
Low 0 0 8 (16)
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the Harbord test.
4243 To assess the effect of the use of
different thresholds to define low pH, we repeated the
meta-analyses using the bivariate method, which takes
into account any threshold effect.
44 We additionally
analysed subgroups within the outcome measures of
neonatal mortality and neonatal morbidity according
to the arterial pH threshold reported (<7.00, <7.10,
and <7.20). We statistically analysed data using Meta-
Disc 1.3 software,
45 and Stata version 10.0 using the
metan, metandi, and meta-bias commands.
46-48
To assess a causal association for each outcome we
consideredHill’scriteria.
2125Weexaminedstrengthof
association using point estimates of odds ratios and
consistency using the direction of association in the
forest plots and heterogeneity statistics.
RESULTS
Aninitialsearchof5690citationsidentified51primary
articles
14510114149-91, two after obtaining information
from the authors (fig 1).
9293 The included studies
totalled 481753 infants. Overall, 190 2×2 tables were
produced; 43 of the studies providing these data were
eligible for inclusion in meta-analyses according to
predefined outcome measures, totalling 479383
infants and 70 2×2 tables. One included study was
thought to contain duplication
60; however, the out-
comes reported were different and therefore both
papers
6061 were included in the review in separate
meta-analyses. When more than one 2×2 table was
produced per study, double counting of infants in any
one analysis was avoided.
The included studies used various index tests
(table 1): most papers (n=46) reported arterial cord
pH,withthresholdsrangingfrom7.00to7.24.Arterial
base excess was reported in four studies, with thresh-
olds of 12-16 mmol/l.
61738191 Five studies reported
venous cord pH; three using a threshold of 7.20 and
one a threshold of 7.10.
5569788593 Only one study
High risk population
  Baenziger et al 199950
  Haddad et a 2000
62
  Hibbard et al 200164
  Beeby et al 1994
4
  Holmes et al 200166
  Tejani and Verma 1989
83
  Yudkin et al 1994
89
  Bresadola et al 199551
  Casey et al 2001
53
  Kato et al 19965
  Luthy et al 1987
74
Unselected population
  Heller et al 20031
  Ingemarrson et al 1997
68
  Vintzileos et al 199390
  Ghosh 2003
57
Subgroup meta-analysis
  High risk population (11 studies)
    Test for heterogeneity: I2=35.1%, P=0.118
  Unselected population (4 studies)
    Test for heterogeneity: I2=0.0%, P=0.985
  High quality studies (7 studies50 53 57 64 74 75)
    Test for heterogeneity: I2=19.9%, P=0.278
  Low or medium quality studies (8 studies1 4 5 51 62 66 68 83)
    Test for heterogeneity: I2=71.7%, P=0.001
Overall: I2=61.0%, Harbord: no small study effects, P=0.111
3.0 (0.1 to 73.6)
1.1 (0.2 to 7.3)
4.3 (1.0 to 18.0)
2.9 (1.6 to 5.4)
5.8 (0.2 to 155.3)
5.3 (2.0 to 13.9)
25.9 (1.3 to 518.6)
11.8 (5.2 to 26.8)
1.9 (0.7 to 4.9)
29.0 (1.4 to 620.7)
3.6 (1.2 to 10.5)
16.2 (9.2 to 31.1)
20.8 (1.0 to 439.0)
18.8 (3.4 to 105.2)
10.1 (0.5 to 218.7)
4.2 (2.6 to 6.9); 1.3-13.7
16.9 (9.7 to 29.5); 5.0-57.3
4.3 (2.2 to 8.5); 1.1-17.0
6.9 (3.1 to 15.2); 0.7-69.2
0.01 1 100
Study Odds ratio
(random effects)
(95% CI); EPI
Odds ratio
(random effects)
(95% CI)
1/2
15/19
4/35
17/88
0/2
8/53
3/3
18/28
11/18
2/2
6/25
11/206
2/2
2/7
2/2
Died
6/8
2/9
132/136
494/535
72/74
328/339
94/119
359/414
912/1673
165/193
160/174
462 597/464 139
247/306
657/671
49/73
Survived
10
28
171
623
76
392
122
452
1691
195
199
464 345
308
678
75
3959
466 406
2946
466 419
No of
neonates
7.00
7.00
7.05
7.10
7.10
7.10
7.10
7.20
7.20
7.20
7.20
7.00
7.00
7.10
7.15
pH
threshold
No of true positives or true
negatives/No with event
Fig 2 | Association of low arterial cord pH with neonatal mortality. EPI=estimated predictive interval
Table 3 |Exploration of heterogeneity in estimation of association between low arterial cord
pH at birth and neonatal mortality and morbidity
Factor
Univariable analysis
Odds ratio (95% CI) P value
Neonatal mortality:
Cohort v case-control design 0.4 (0.03 to 6.5) 0.52
High quality v medium or low quality study 0.8 (0.3 to 2.4) 0.63
High risk v unselected population 0.3 (0.1 to 1.0) 0.048*
Composite neonatal morbidity:
Cohort v case-control design 1.1 (0.2 to 5.3) 0.90
High quality v medium or low quality study 1.4 (0.5 to 3.7) 0.51
High risk v unselected or low risk population 0.4 (0.2 to 0.9) 0.03*
Dummy variables were used to set the reference category as medium or low quality, case-control design, and
unselected or low risk population.
*P<0.05.
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93 The cord pH level was
obtained before the occurrence of the adverse out-
come. A wide variety of outcome measures were
reported, ranging from neonatal mortality and mor-
bidity to long term outcomes, including cerebral
palsy, unspecified neurological abnormality, IQs, and
developmental assessments (for example, Bayley and
Griffiths scores). When the same outcome was
reported, the thresholds and ages at assessment varied
between studies, therefore meta-analysis was not pos-
sibleforlongtermoutcomesotherthancerebralpalsy.
Theoddsratiopoint estimatevariedwidely.Thirtysix
studies reported on outcomes within the neonatal per-
iod only. Fifteen studies had long term follow-up; one
didnotreporttheageofascertainmentoftheoutcome.
The age range reported in other studies was 1 to
8 years; the median across studies was 5 years.
Quality assessment
Overall, study quality wasvariable (table 2). Moststu-
dieswereretrospectivebutwithacohortdesign,allow-
inginferencesontemporalityofassociation.Over80%
of studies met the following quality items: appropriate
outcome measure, more than 90% verification with
outcome measure, and cohort design. Studies scored
poorly for adequate description of index test and out-
come measure, and consecutive recruitment. All
includedstudieswere unclearaboutthe useofmedical
interventionbetweentheindextestand outcomemea-
sure. Overall, 45% (n=23) of studies were of high qual-
ity, 39% (n=20) of medium quality, and 16% (n=8) of
low quality. Study design and quality did not seem to
influence results on metaregression (table 3).
Association between cord pH and neonatal mortality
Fifteen studies (13 cohort, two case-control) totalling
469395 infants reported on the association between
arterial cord pH and mortality. The Harbord test was
not significant, suggesting no influence of small study
effect (see web extra on bmj.com). All studies had an
oddsratiopointestimategreaterthan1.0.Heterogene-
ity was significant (I
2=61.0%) overall. Metaregression
(table 3) identified population risk as a significant
explanatory factor. Within subgroups (fig 2) the asso-
ciationwasconsistentacrossstudies.Theassociationof
lowarterialcordpHwithneonatalmortalitywasstron-
ger in the unselected population (odds ratio 16.9, 95%
confidence interval 9.7 to 29.5, estimated predictive
interval5.0-57.3,I
2=0.0%)thaninthehighriskpopula-
tion (4.2, 2.6 to 6.9, 1.3-13.7, I
2=35.1%). The analysis
for the unselected population was dominated by one
large study,
1 which was based on data from a regional
perinatal register where cord pH was determined at
most of the births. A sensitivity analysis excluding
this study this did not significantly alter the point esti-
mate(17.0,4.4to65.5);however,theestimatedpredic-
tive interval became wide (0.0-106299.0)
Examination of the high risk population further
showed that when studies reporting on a population
of infants born at less than 32 weeks’ gestation, or
with a birth weight of less than 2000 g, were analysed
Table 4 |Effect of using varying thresholds of arterial cord pH at birth on accuracy to predict
neonatal morbidity and mortality
Variables Odds ratio (95% CI)
Overall odds ratio (95% CI);
estimated predictive interval
Neonatal mortality
pH threshold 7.00:
Baenziger et al 1999
50 3.00 (0.1 to 73.6)
6.1 (0.90 to 41.6); 0.0-20406.6
Haddad et al 2000
62 1.07 (0.2 to 7.3)
Heller et al 2003
1 16.9 (9.2 to 31.1)
Ingemarrson et al 1997
68 20.8 (1.0 to 439.0)
pH threshold 7.10:
Beeby et al 1994
4 2.9 (1.6 to 5.4)
7.1 (3.3 to 15.3); 0.8-64.3
Heller et al 2003
1 10.6 (7.4 to 15.1)
Holmes et al 2001
66 5.8 (0.2 to 155.3)
Vintzileos et al 1993
90 18.8 (3.4 to 105.2)
Yudkin et al 1994
89 25.9 (1.3 to 518.6)
pH threshold 7.20:
Bresadola et al 1995
51 11.8 (5.2 to 26.8)
4.3 (2.2 to 8.7); 0.5-40.7
Casey et al 2001
53 1.9 (0.7 to 4.9)
Heller et al 2003
1 3.1 (2.3 to 4.1)
Kato et al 1996
5 29.0 (1.4 to 10.5)
Luthy et al 1987
74 3.6 (1.2 to 10.5)
Neonatal morbidity
pH threshold 7.00:
Baenziger et al 1999
50 2.7 (0.2 to 45.1)
12.5 (6.1 to 25.6); 1.7-89.9
Engle et al 1999
56 42.4 (2.3 to 782.1)
Graham et al 2002
60 22.9 (1.1 to 494.6)
Gonzalez de Dios 2000
59 9.2 (3.2 to 26.5)
Haddad et al 2000
62 8.0 (0.3 to 255.8)
Hernandez et al 1993
63 2.4 (0.8 to 7.4)
Ingemarrson et al 1997
68 18.5 (3.8 to 89.6)
Larma et al 2007
70 8.6 (1.1 to 69.7)
Loh et al 1998
72 92.1 (3.7 to 2309.1)
Perlman 1996
76 50.3 (2.7 to 955.6)
Silva et al 2008
80 47.4 (2.2 to 1030.3)
Socol 1994
81 14.4 (0.7 to 311.8)
Valentin et al 1993
85 1.8 (0.2 to 15.8)
Van den Berg 1996
10 10.0 (1.2 to 80.5)
Gilstrap et al 1989
58 169.9 (22.5 to 1281.4)
pH threshold 7.10:
Beeby et al 1994
4 3.9 (1.9 to 7.9)
2.4 (1.3 to 4.2); 0.4-12.7
Dijxhoorn et al 1986
41 0.3 (0.04 to 13.4)
Ertan et al 2006
91 2.0 (0.9 to 4.5)
Hernandez et al 1993
63 1.6 (0.6 to 4.1)
Holmes et al 2001
66 3.1 (0.1 to 75.5)
Huisjes 1979
67 4.8 (2.6 to 8.7)
Silva et al 2008
80 14.7 (4.3 to 50.6)
Tejani 1989
83 1.2 (0.3 to 4.3)
Valentin et al 1993
85 0.8 (0.2 to 3.9)
Salafia et al 1995
78 0.7 (0.04 to 13.4)
pH threshold 7.20:
Blackwell et al 2001
52 1.0 (0.3 to 4.2)
2.2 (1.3 to 3.7); 0.5-9.9
Casey et al 2001
53 3.1 (1.8 to 5.3)
Dijxhoorn et al 1986
41 1.4 (0.6 to 3.0)
Hernandez et al 1993
63 1.6 (0.7 to 3.9)
Luthy et al 1987
74 5.5 (1.9 to 15.7)
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BMJ | ONLINE FIRST | bmj.com page 7 of 13separately (seven studies), a significant association was
found between cord pH and mortality (3.5, 2.3 to 5.4,
I
2=0.0%). When limited to a term (>37 weeks’ gesta-
tion)population(fourstudies),the associationwasalso
strong (9.3, 1.4 to 63.2, I
2=84.0%); however, heteroge-
neity was significant and the predictive interval broad
(0.0-38169.8).Groupingthestudiesaccordingtoqual-
ity did not affect the significance or direction of
High risk population
  Baenziger et al 199950
  Engle et al 1999
56
  Gonzalez de Dios et al  200059
  Graham et al 200260
  Graham et al 2004
61
  Haddad et al 2000
62
  Hernandez et al 1993
63
  Loh et al 1998
72
  Socol 1994
81
  Hibbard et al 2001
64
  Beeby et al 1994
4
  Ertan et al 2006
91
  Holmes et al 2001
66
  Salafia et al 1995
78
  Tejani and Verma 1989
83
  Yoon et al 1996
88
  Blackwell et al 2001
52
  Casey et al 2001
53
  Luthy et al 1987
74
Unselected or low risk population
  Gilstrap et al 198958
  Ingemarrson et al 1997
68
  Larma et al 2007
70
  Perlman and Risser 1996
76
  Silva et al 2008
80
  Valentin et al 1993
85
  Van den Berg 199610
  Huisjes and Aarnoudse 1979
67
  Litschgi et al 1974
71
  Dijxhoorn et al 1986
41
  Ghosh 200357
  Sakaruba and Saling 1989
77
Subgroup meta-analysis
  Composite morbidity in high risk population (18 studies)
    Test for heterogeneity: I2=26.4%, P=0.146
  Composite morbidity in unselected or low risk population (12 studies)
    Test for heterogeneity: I2=66.4%, P=0.001
  HIE (any population) (7 studies)
    Test for heterogeneity: I2=0.0%, P=0.525
  Seizures (any population) (9 studies)
    Test for heterogeneity: I2=66.3%, P=0.003
  IVH or PVL (any population) (12 studies)
    Test for heterogeneity: I2=0.0%, P=0.666
Overall: I2=58.2%, Harbord test P=0.006
2.7 (0.2 to 45.1)
42.4 (2.3 to 782.1)
9.2 (3.2 to 26.5)
22.9 (1.1 to 494.6)
1.7 (0.3 to 10.6)
8.0 (0.3 to 255.8)
2.4 (0.8 to 7.4)
92.1 (3.7 to 2309.1)
14.4 (0.7 to 311.8)
1.4 (0.2 to 12.4)
3.7 (0.9 to 16.2)
3.9 (1.9 to 7.9)
2.0 (0.9 to 4.4)
3.1 (0.1 to 75.5)
0.7 (0.04 to 13.4)
1.2 (0.3 to 4.3)
4.0 (1.5 to 11.1)
1.0 (0.8 to 4.2)
3.1 (1.8 to 5.3)
5.5 (1.9 to 15.7)
169.9 (22.5 to 1281.4)
18.5 (3.8 to 89.6)
8.6 (1.1 to 69.7)
1.8 (0.5 to 6.4)
50.3 (2.7 to 955.6)
47.4 (2.2 to 1030.3)
3.3 (0.8 to 13.4)
1.8 (0.2 to 15.8)
10.0 (1.2 to 80.5)
2.6 (0.5 to 13.8)
4.8 (2.6 to 8.7)
14.3 (6.6 to 31.0)
0.3 (0.04 to 2.3)
63.0 (3.5 to 1135.0)
8.9 (1.4 to 58.8)
3.4 (2.3 to 4.9); 1.4-8.4
10.6 (4.7 to 24.1); 0.8-135.8
13.8 (6.6 to 28.9); 5.2-36.4
8.1 (3.0 to 21.9); 0.4-153.6
2.9 (2.1 to 4.1); 2.0-4.3
0.01 1
*Not included in meta-analysis of any morbidity
100
Study Odds ratio
(random effects)
(95% CI); EPI
Odds ratio
(random effects)
(95% CI)
2/5
7/7
12/41
3/10
3/107
8/9
11/39
2/2
3/3
1/18
5/55
13/48
24/60
0/4
0/44
3/53
8/20
1/1
47/66
17/33
2/2
8/10
8/9
7/11
5/5
2/2
2/11
1/8
9/10
5/7
20/54
12/50
1/27
10/10
2/5
Affected
HIE (Sarnat grade >1)
HIE plus seizures (NS)
HIE (Levine, all grades)
Seizures (NS)
PVL (NS)
HIE (NS)
Mechanical ventilation
HIE (NS)
Seizures (NS)
Seizures/atrophy (NS)
IVH (NS)
IVH (Papile grade 3 or 4)
IVH (Papile, all grades)
IVH (Papile grade 3 or 4)
IVH (NS)
IVH (Papile, all grades)
PVL (cystic/echogenic WM)
Seizures (NS)
Seizures (NS)
IVH (Papile grade 3 or 4)
Seizures (NS)
HIE (NS)
Seizures (NS)
IVH (NS)
Seizures (Volpe)
HIE (NS)
Seizures (NS)
Composite morbidity (grade 4/5)
Seizures (NS)
IVH (NS)
Abnormal neurology (Prechtl)
Abnormal neurology (NS)
Abnormal tone/movement
HIE (NS)
IVH (NS)
Outcome measure
(definition)
4/5
49/56
133/139
24/24
120/122
1/2
37/43
64/67
17/25
144/150
112/115
447/490
45/60
70/72
357/362
323/339
114/133
5/7
900/1625
163/176
2718/2734
345/298
106/205
103/203
75/90
156/172
147/162
151/163
83/158
82/161
698/784
934/962
691/776
49/55
161/173
Unaffected
10
73
180
34
229
11
82
69
28
168
170
538
120
76
406
392
153
8
1691
209
2736
308
214
214
95
174
173
171
168
168
838
1012
803
75
178
4339
5977
827
5147
2853
No of
neonates
7.00
7.00
7.00
7.00
7.00
7.00
7.00
7.00
7.00
7.05
7.05
7.10
7.10
7.10
7.10
7.10
7.15
7.20
7.20
7.20
7.00
7.00
7.00
7.00
7.00
7.00
7.00
7.00
7.00
7.00
7.09
7.09
7.10
7.15
7.19
pH
threshold
No of true positives or true negatives/
No affected or unaffected
Fig 3 | Association of low arterial cord pH with neonatal morbidity. HIE=hypoxic ischaemic encephalopathy; IVH=intraventricular haemorrhage;
PVL=periventricular leucomalacia; NS=not stated; WM=cerebral white matter; EPI=estimated predictive interval
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threshold effect (table 4) showed that for a cut-off pH
threshold of 7.00 the association did not reach signifi-
canceoverall (6.1,0.9to41.6) andthe predictiveinter-
val was broad (0.0-20406.6). The results for a
threshold of 7.10 gave a similar point estimate but
achieved significance (7.1, 3.3 to 15.3); however, the
predictive interval remained broad (0.8-64.3) and
crossed the line of no effect. For a threshold of 7.20,
the odds ratio was lower (4.3, 2.2 to 8.7), with a broad
predictive interval (0.5-40.6). Only one study exam-
ined all three thresholds,
1 with the strongest associa-
tion at threshold 7.00 (16.9, 9.2 to 31.1) and the
weakest at 7.20 (3.1, 2.3 to 4.1).
Association between cord pH and neonatal morbidity
Thirty one studies compared arterial cord pH with a
variety of neonatal outcomes (fig 3). One of these
61
was excluded from meta-analysis of composite neona-
tal morbidity because it contained a duplicate popula-
tion to another included study,
60 therefore the dataset
toassesstheassociationofarterialpHwithacomposite
measure of morbidity included 30 studies with 10904
infants. The Harbord test was significant, suggesting
the presence of a small study effect (see web extra on
bmj.com). Only two studies had an odds ratio point
estimate of less than 1.0, the rest showing an associa-
tion. Significant heterogeneity was, however, present
(I
2=58.2%). Metaregression showed population to be
anexplanatoryvariable(table 3).Subgroupmeta-ana-
lysis for a high risk population (fig 3) showed a weaker
association(3.4,2.3to4.9,1.4-8.4,I
2=26.4%)thaninan
unselected or undefined population (10.6, 4.7 to 24.1,
0.8-135.8, I
2=66.4%). When analysed in subgroups
according to quality, the direction of effect remained
consistentandsignificantbetweenthegroupof12high
qualitystudies(6.6,3.7to11.8,1.3-32.6,I
2=51.2%)and
18 low or medium quality studies (4.6, 2.6 to 8.0, 0.7-
29.2, I
2=61.5%). Exploration by subgroup analysis for
athresholdeffect(table 4)showedthemostsubstantial
associationatapHthresholdof7.00(12.5,6.1to25.6).
Thepredictiveintervalwasbroadbutdidnotcrossthe
lineofnoeffect(1.7-89.9).Theresultsweresimilarfora
threshold of 7.10 (2.4, 1.3 to 4.3) and 7.20 (2.2, 1.3 to
3.7).
When components of the composite outcome were
analysed (fig 3), the odds ratio for an association
betweenarterialcordpHandhypoxicischaemicence-
phalopathy was 13.8 (6.6 to 28.9, 5.2-36.4, I
2=0.0%),
between arterial cord pH and seizures was 8.1 (3.0 to
21.9, 0.4-153.6, I
2=66.3%), and between intra-
ventricular haemorrhage or periventricular leucoma-
lacia was 2.9 (2.1 to 4.1, 2.0-4.3, I
2=0.0%). Only two
ofninestudiesreportingthisoutcomewerenotlimited
to a preterm (<32 weeks) or low birthweight (<2000 g)
population. Excluding these two studies did not affect
the strength or significance of the association.
Five studies reported on the association between
venous cord pH and neonatal morbidity.
5569788593
Meta-analysis showed a significant association (4.0,
1.2to13.3,I
2=44.5%).Howeverthepredictiveinterval
crossed the line of no effect (0.1-125.3). Four studies
examined the association between arterial base excess
and neonatal morbidity, which was similar to venous
cord pH and also had an estimated predictive interval
that crossed the line of no effect (2.5, 1.3 to 4.8, 0.6-
10.4, I
2=0.0%).
61738191 Owing to the small number of
studies reporting this variable, it was not possible to
combine the cord pH and base excess to compare the
differencebetweenrespiratoryandmetabolicacidosis.
Association between cord pH and cerebral palsy
Sevenstudiestotalling1117infantsexaminedtheasso-
ciation between arterial cord pH and cerebral
palsy.
454968747581 Of those, two had an odds ratio
point estimate of less than 1.0, but the rest showed an
association of low pH with cerebral palsy (table 4).
Only two studies gave the criteria used to diagnose
cerebral palsy.
4975 The overall association was odds
ratio 2.3 (1.3 to 4.2, 1.1-5.0, I
2=0.0%l fig 4). It was not
possible to explore the threshold effect by subgroup
analysisowingtothesmallnumberofstudiesreporting
this outcome, therefore bivariate meta-analysis was
carried out, which did not change the overall results
(2.1, 1.2 to 4.1).
Ingemarrson et al 199768
Socol 199481
Gaudier et al 199449
Beeby et al 1994
4
Murphy et al 199575
Kato et al 19965
Luthy et al 198774
Overall (7 studies)
  Test for heterogeneity: I2=0.0%, P=0.777
0.5 (0.02 to 9.6)
5.0 (0.3 to 72.8)
2.9 (0.7 to 11.9)
0.7 (0.1 to 5.7)
2.3 (0.8 to 6.8)
3.9 (0.9 to 18.1)
2.2 (0.5 to 8.5)
2.3 (1.3 to 4.2); 1.1-5.0
0.01 1 100
Study
Odds ratio
(random effects)
(95% CI); EPI
Odds ratio
(random effects)
(95% CI)
0/2
5/6
3/30
1/20
6/24
3/8
3/19
Cerebral
palsy
NS
NS
Abnormal movements/posture
NS
Permanent movement disorder
NS
NS
Definition
139/200
3/6
182/189
219/235
112/128
98/113
126/137
No cerebral
palsy
202
12
219
255
152
121
156
1117
No of
children
7.00
7.00
7.05
7.10
7.10
7.20
7.20
pH
threshold
No of true positives or true negatives/
No with or without cerebral palsy
Fig 4 | Association of low arterial cord pH with cerebral palsy. NS=not stated; EPI=estimated predictive interval
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Low arterial umbilical cord pH had a strong, consis-
tent, and temporal association with neonatal mortality
and morbidity (composite of hypoxic ischaemic ence-
phalopathy, seizures, and intraventricular haemor-
rhage or periventricular leucomalacia) and long term
outcome (cerebral palsy). In all of the associations
between arterial cord pH and outcome explored,
with the exception of composite morbidity in a low
risk population and seizures, the estimated predictive
interval suggested that a future study would have the
samedirectionandsignificanceofeffectobserved.The
associations observed are biologically plausible.
694-96
Strengths and limitations of the review
Thisreviewprovidesthebestavailableevidence,atthe
timeofpublication,oftheassociationbetweencordpH
at birth and outcomes. The strength of our review and
the validity of our inferences lie in the methods used.
Wecompliedwithexistingguidelinesforthereporting
of systematic reviews of diagnostic
2297 and observa-
tional studies evaluating causal association.
1525 We
used the most up to date techniques for carrying out
andinterpretingmeta-analysis.
3544Anextensivelitera-
turesearchwasdoneinrelevantdatabaseswithnolan-
guage restrictions applied. The studies we pooled had
heterogeneity in terms of quality, population risk,
threshold of cord pH used, and ascertainment of neo-
nataloutcome.Wecarriedoutrecommendedanalyses
to tackle this problem, including bivariate and sub-
group meta-analysis to take into account the threshold
effect,
44 metaregression analysis to explore reasons for
heterogeneity,
39 and component outcome analysis to
examinethesuitabilityofthecompositemorbidityout-
come. This did not significantly affect our results.
Recent work suggesting the differences between stan-
dard and bivariate techniques may be small.
98 The
observed associations were qualitatively in the same
direction, and statistical heterogeneity, when present,
arose from variation in strength of associations from
study to study rather than opposition in direction of
association. We are therefore confident that our infer-
ence concerning a causal association between low
arterial cord pH at birth and neonatal mortality and a
variety of neonatal morbidities merits consideration.
This review has several limitations. Despite our
efforts to search for published and unpublished litera-
ture, the Harbord test suggested that the meta-analysis
oftherelationofarterialcordpHandneonatalmorbid-
ity may be affected by small study bias. The quality of
the primary studies varied. We used both meta-
regression and subgroup analysis to explore for the
effectofthisproblem,whichshowedthatstudyquality
did not affect our inferences. The poor reporting of
population characteristics limited the subgroup analy-
sis according to risk factors: a large number of the
papers with an “unselected” population did not fully
report characteristics such as birth weight or gesta-
tional age, making it difficult to extrapolate our find-
ings to the general obstetric population. Only one
paper included in the meta-analysis specified that it
was limited to a low risk term population. With regard
to the index test examined, only a small number of
papers reported base excess, which meant that it was
not possible to compare metabolic acidosis with
respiratory acidosis. We found that a high base excess
was associated with neonatal morbidity, but in clinical
practicethepHandbaseexcesslevelwouldbeconsid-
ered together in any infant, and we are unable to com-
ment on this. Additionally, we were only able to base
our analysis on the thresholds reported in the primary
studies, which limited our exploration of the effect of
varying pH levels. Some of these issues may be dealt
with using meta-analysis of individual patient data.
99
Venous cord pH and arterial base excess showed
weaker associations with neonatal morbidity than
thatofarterialcordpH,withestimatedpredictiveinter-
valsthatcrossedthelineofnoeffect.Thisanalysiswas,
however,basedonasmallnumberofstudies,andasno
other subgroup analysis could be done, a direct com-
parisonwitharterialcordpHwasnotpossible.Itseems
likelyfromourresultsthatarterialcordpHhasastron-
ger association with outcome than venous cord pH.
Evidence supporting causality of association of low arterial
cord pH with adverse outcomes
Hypoxic ischaemia initiates energy depletion, the
accumulation of extracellular glutamate, and activa-
tion of receptors, leading to a deleterious cascade of
events resulting in neuronal death.
100 However, differ-
entareasofthebrainaresusceptibletoinjuryatvarious
stages in development, and the consequences of injury
are unpredictable.
101 This would support our findings
of a strong association with hypoxic ischaemic ence-
phalopathy but a weaker association with cerebral
palsy. Only 10% of infants with evidence of hypoxic
ischaemic encephalopathy develop cerebral palsy,
but the reasons for this are not yet fully
understood.
102 This issue is further highlighted by the
findings of the term breech trial, where long term fol-
low-up did not show any difference in neurodevelop-
mental delay, despite an apparent increase in neonatal
morbidity in the vaginal breech group.
103
It is difficult to comment on the specificity with
which cord pH is associated with the outcomes exam-
ined within our review. All of the outcomes may arise
from a variety of causes—for example, in addition to
hypoxia, neonatal seizures may be caused by congeni-
tal brain anomaly, infection, and metabolic disorders.
Although some of the included studies excluded
infantswithcongenitalanomaly,othersdidnotspecify
whether they had excluded from their analysis infants
with an outcome related to another cause. This may
explain why the strength of association of arterial
cord pH with neonatal mortality and morbidity was
stronger in the unselected group than in the high risk
group. The infants in the high risk group had other
factors (for example, prematurity, low birth weight)
that may have contributed to the adverse outcome,
thus diluting the strength of association. This is sup-
ported by the higher number of deaths in the high
RESEARCH
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ial cord pH and death in the unselected population.
We explored for the presence of a dose-response
relation by examining the strength of association
between arterial cord pH and neonatal mortality and
morbidity at different pH thresholds. Although the
meta-analysis did not show a clear dose-response rela-
tion,andtheestimatedpredictiveintervalswerebroad,
the association for both neonatal mortality and neona-
tal morbidity was weakest at the highest threshold.
Only one study
1 explored the association of arterial
cord pH and neonatal mortality at all three thresholds
examined. A clear dose-response relation was appar-
ent withinthisstudy,withthe strongestassociationata
thresholdof7.00andtheweakestatathresholdof7.20.
Comparison within a study may be more valid than
comparisons between studies as it avoids confounding
by other study level factors.
Conclusions and practice implications
Our review did not explore the use of cord pH as a
prognostic test, and therefore the extent to which our
results can be used to counsel parents and target inter-
ventions for infants with a low cord pH at birth is lim-
ited. To explore this matter, further research is
required. A recent review highlighted the current def-
icits in prognosis research and suggested that when
high quality primary studies exist, meta-analysis of
individual patient data enables the prognostic value
of a test to be assessed at an individual level.
104 Our
review, however, highlights the lack of high quality
primary studies, and therefore a large prospective
cohort study with long term follow-up and accounting
for potential confounding factors is required. Such a
study must include evaluation of outcomes relevant
to the individual and society, such as impaired devel-
opment and use of healthcare and educational
resources, before the evaluation of use of cord pH as
a prognostic test and its cost effectiveness. This will
enable further exploration of the threshold effect and
theuseofcombinedcordpHandbaseexcesstopredict
outcome.
Cord pH is currently assessed in infants believed to
be at high risk for neonatal asphyxia. Our results sug-
gest,however,thatthestrengthofassociationwithcord
pHandoutcomeisnotlimitedtothishighriskpopula-
tion.Thereforefutureresearchshouldassesstheuseof
cord pH across neonatal populations, particularly
exploring the cost effectiveness of testing all neonates.
Systematicreviewstoestablishtheassociationofother
neonatalwellbeingmeasureswithlongtermoutcomes
are ongoing in our department.
Basedonourreview,increasedinitialsurveillanceof
neonates born with a low arterial cord pH, regardless
of their clinical condition, is warranted as the odds of
complications have been shown to be higher in this
group.The avoidanceofa low cordpH atbirth should
continuetobeatargetfordaytodayobstetricpractice.
Our findings justify the use of arterial cord pH as an
important outcome measure alongside neonatal mor-
bidity and mortality in obstetric clinical trials. It is dif-
ficult to draw strong conclusions on the necessity of
long term follow-up for babies with low arterial cord
pH,astheobservedassociationwithcerebralpalsywas
inalimitednumberofprimarystudiesandtheassocia-
tion, althoughstatistically significant,was only moder-
ately strong and based on studies of varying quality.
We therefore support the use of long term follow-up
with childhood assessments in obstetric trials, as this
mayshowdevelopmentalanomaliesandallowevalua-
tion of cord pH as a predictive test for these outcomes.
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